IN2012DN06631A - - Google Patents
Info
- Publication number
- IN2012DN06631A IN2012DN06631A IN6631DEN2012A IN2012DN06631A IN 2012DN06631 A IN2012DN06631 A IN 2012DN06631A IN 6631DEN2012 A IN6631DEN2012 A IN 6631DEN2012A IN 2012DN06631 A IN2012DN06631 A IN 2012DN06631A
- Authority
- IN
- India
- Prior art keywords
- yloxy
- methyl
- isoxazol
- pyran
- piperidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30492110P | 2010-02-16 | 2010-02-16 | |
| PCT/IB2011/050548 WO2011101774A1 (en) | 2010-02-16 | 2011-02-09 | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN06631A true IN2012DN06631A (de) | 2015-10-23 |
Family
ID=43904611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6631DEN2012 IN2012DN06631A (de) | 2010-02-16 | 2011-02-09 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120041026A1 (de) |
| EP (1) | EP2536713A1 (de) |
| JP (1) | JP2013519722A (de) |
| KR (1) | KR20120123089A (de) |
| CN (1) | CN102762554A (de) |
| AR (1) | AR080172A1 (de) |
| AU (1) | AU2011216950A1 (de) |
| CA (1) | CA2788656A1 (de) |
| IN (1) | IN2012DN06631A (de) |
| MX (1) | MX2012008721A (de) |
| SG (1) | SG183111A1 (de) |
| TW (1) | TW201141856A (de) |
| UY (1) | UY33225A (de) |
| WO (1) | WO2011101774A1 (de) |
| ZA (1) | ZA201206469B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9737531B2 (en) * | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| US10583138B2 (en) | 2012-07-12 | 2020-03-10 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| CN103702995B (zh) * | 2011-05-18 | 2016-04-13 | 拉夸里亚创药株式会社 | 4-{[4-({[4-(2,2,2-三氟乙氧基)-1,2-苯并异噁唑-3-基]氧}甲基)哌啶-1-基]甲基}-四氢-2h-吡喃-4-羧酸的多晶型形式 |
| EP2922849B1 (de) * | 2012-11-21 | 2017-07-12 | RaQualia Pharma Inc. | Polymorphe der 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carbonsäure als 5-hydroxytryptamin-4 (5-ht4) rezeptor agonisten zur behandlung von magen-darm-erkrankungen |
| ES2674993T3 (es) | 2013-03-20 | 2018-07-05 | Suven Life Sciences Limited | Derivados de 5-amino-quinolina-8-carboxamida como agonistas del receptor 5-HT4 |
| US9951045B2 (en) | 2013-12-16 | 2018-04-24 | Suven Life Sciences Limited | Indazole compounds as 5-HT4 receptor agonists |
| TWI672300B (zh) * | 2014-05-20 | 2019-09-21 | 日商拉夸里亞創藥股份有限公司 | 苯并異唑衍生物鹽類 |
| LT3265459T (lt) | 2015-02-13 | 2019-08-26 | Suven Life Sciences Limited | Amidų junginiai, kaip 5-ht4 receptorių agonistai |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2089511T3 (es) | 1991-02-27 | 1996-10-01 | Merrell Pharma Inc | Dihidroquinolina antagonistas de nmda. |
| US5750542A (en) * | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DE69332691T2 (de) * | 1992-11-23 | 2003-12-18 | Aventis Pharma Inc | Substituierte 3-(aminoalkylamino)-1,2-benzisoxazole und verwandte verbindungen |
| IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| AU708148B2 (en) | 1995-09-29 | 1999-07-29 | Glaxo Wellcome S.P.A. | Tetrahydroquinolines as NMDA antagonists |
| IL126003A0 (en) | 1996-04-10 | 1999-04-11 | Hoechst Marion Roussel Inc | Spiro [cyclopent [b] indole-piperidines] and n-[phenyl-hydrazon intermediates for their preparation both being acetyl cholinesterase and mao inhibitors |
| IL126308A0 (en) | 1996-04-12 | 1999-05-09 | Hoechst Marion Roussel Inc | Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| ATE224884T1 (de) | 1996-07-01 | 2002-10-15 | Schering Corp | Muscarin-antagonisten |
| CA2263167C (en) | 1996-08-15 | 2006-02-14 | Schering Corporation | Ether muscarinic antagonists |
| CA2266556C (en) | 1996-09-30 | 2007-11-06 | Hoechst Marion Roussel, Inc. | Nmda (n-methyl-d-aspartate) antagonists |
| CN1535682A (zh) | 1998-09-30 | 2004-10-13 | ����ҩƷ��ҵ��ʽ���� | 改善膀胱排泄能力的药物 |
| AU2002226687B9 (en) | 2001-01-26 | 2005-10-20 | Btg International Limited | Benzylamine analogue |
| JP2005506292A (ja) | 2001-03-08 | 2005-03-03 | エモリー ユニバーシティ | ｐＨに依存するＮＭＤＡレセプターアンタゴニスト |
| JP2005511478A (ja) | 2001-04-03 | 2005-04-28 | メルク エンド カムパニー インコーポレーテッド | Ｎ−置換非アリール複素環アミジル系ｎｍｄａ／ｎｒ２ｂ拮抗薬 |
| ES2312603T3 (es) | 2001-07-24 | 2009-03-01 | Richter Gedeon Nyrt | Derivados de piperidina como antagonistas del receptor nmda. |
| JP3927228B2 (ja) | 2003-06-04 | 2007-06-06 | メルク エンド カムパニー インコーポレーテッド | Ｎｍｄａ／ｎｒ２ｂ拮抗物質としての３−フルオロ−ピペリジン |
| GB0316094D0 (en) | 2003-07-09 | 2003-08-13 | Neuropharma Sa | Acetylcholinesterase dual inhibitors |
| PT1729821E (pt) * | 2004-03-03 | 2013-10-23 | Revance Therapeutics Inc | Composições e métodos para aplicação tópica e administração transdérmica de toxinas botulínicas |
| HU227119B1 (en) | 2004-07-29 | 2010-07-28 | Richter Gedeon Nyrt | Indole and benzimidazole carboxylic acid amide derivatives and pharmaceutical compositions containing them |
| HU227000B1 (en) | 2004-07-29 | 2010-04-28 | Richter Gedeon Nyrt | Nmda receptor antagonist benzoyl urea derivatives, and pharmaceutical compositions containing them |
| HUP0401522A2 (en) | 2004-07-29 | 2006-04-28 | Richter Gedeon Vegyeszet | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation |
| HUP0401523A3 (en) | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
| HU226977B1 (en) | 2004-07-29 | 2010-04-28 | Richter Gedeon Nyrt | Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them |
| TW200621677A (en) | 2004-09-21 | 2006-07-01 | Astellas Pharma Inc | Cyclic amine derivative or salt thereof |
| US8273893B2 (en) | 2004-10-15 | 2012-09-25 | Viegas Jr Claudio | Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes |
| US8816090B2 (en) | 2005-02-25 | 2014-08-26 | Pfizer Inc. | Benzisoxazole derivatives |
| US20090124600A1 (en) | 2005-04-19 | 2009-05-14 | Layton Mark E | N-Alkyl-Azacycloalkyl NMDA/NR2B Antagonists |
| JP2009503520A (ja) | 2005-07-29 | 2009-01-29 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | ベータアミロイド受容体及びその使用 |
| JP2009531323A (ja) | 2006-03-20 | 2009-09-03 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | アセチルコリンエステラーゼ阻害剤として有用な薬剤組成物 |
| ES2288406B1 (es) | 2006-04-20 | 2008-12-16 | Universidad De Barcelona | Compuestos inhibidores de acetilcolinesterasa para el tratamiento de la enfermedad de alzheimer. |
| JP2010513395A (ja) | 2006-12-20 | 2010-04-30 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | カンナビノイド−ｃｂ１拮抗作用とアセチルコリンエステラーゼ阻害の組み合わせを示す化合物 |
| US7605265B2 (en) | 2007-01-22 | 2009-10-20 | Biotechnology Research Corporation Ltd. | Heterodimers and methods of using them |
| DK2345653T3 (da) | 2007-05-01 | 2013-04-08 | Concert Pharmaceuticals Inc | Morphinanforbindelser |
| CN104844678B (zh) | 2007-05-11 | 2018-02-09 | 香港科技大学 | 具有神经保护和增强记忆活性的受体调节剂 |
| NZ582917A (en) | 2007-06-29 | 2013-01-25 | Univ Emory | Nmda receptor antagonists for neuroprotection |
| WO2009036235A2 (en) | 2007-09-12 | 2009-03-19 | Virginia Tech Intellectual Properties, Inc. | Insecticidal carbamates exhibiting species-selective inhibition of acetylcholinesterase (ache) |
| WO2009092324A1 (en) | 2008-01-16 | 2009-07-30 | Hong Kong University Of Science And Technology | Oxazolidine derivatives as nmda antagonists |
| EA014100B1 (ru) | 2008-02-21 | 2010-08-30 | Общество С Ограниченной Ответственностью "Валексфарм" | Производные 2,4-диаминопиридина, фармацевтическая композиция, лекарственное средство на их основе для лечения или предупреждения заболеваний и нарушений, вызванных гиперактивацией nmda-рецепторов и/или в качестве стимуляторов когнитивных функций и способ лечения |
| CN101440061B (zh) | 2008-04-08 | 2010-12-08 | 温州医学院 | 一类具有抑制乙酰胆碱酯酶活性的芳基吡啶酮类衍生物 |
| WO2009129181A1 (en) | 2008-04-14 | 2009-10-22 | Concert Pharmaceuticals Inc. | Propanediol-dicarbamate derivatives |
| MX2010012186A (es) | 2008-05-09 | 2011-02-22 | Univ Emory | Antagonistas del receptor nmda para el tratamiento de transtornos neuropsiquitricos. |
-
2011
- 2011-02-09 SG SG2012053906A patent/SG183111A1/en unknown
- 2011-02-09 AU AU2011216950A patent/AU2011216950A1/en not_active Abandoned
- 2011-02-09 IN IN6631DEN2012 patent/IN2012DN06631A/en unknown
- 2011-02-09 EP EP11710564A patent/EP2536713A1/de not_active Withdrawn
- 2011-02-09 JP JP2012553423A patent/JP2013519722A/ja not_active Withdrawn
- 2011-02-09 WO PCT/IB2011/050548 patent/WO2011101774A1/en active Application Filing
- 2011-02-09 KR KR1020127021310A patent/KR20120123089A/ko not_active Application Discontinuation
- 2011-02-09 MX MX2012008721A patent/MX2012008721A/es not_active Application Discontinuation
- 2011-02-09 CN CN2011800099647A patent/CN102762554A/zh active Pending
- 2011-02-09 CA CA2788656A patent/CA2788656A1/en not_active Abandoned
- 2011-02-14 AR ARP110100443A patent/AR080172A1/es not_active Application Discontinuation
- 2011-02-14 UY UY0001033225A patent/UY33225A/es not_active Application Discontinuation
- 2011-02-15 TW TW100104942A patent/TW201141856A/zh unknown
- 2011-02-16 US US13/028,368 patent/US20120041026A1/en not_active Abandoned
-
2012
- 2012-08-28 ZA ZA2012/06469A patent/ZA201206469B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102762554A (zh) | 2012-10-31 |
| AR080172A1 (es) | 2012-03-21 |
| EP2536713A1 (de) | 2012-12-26 |
| KR20120123089A (ko) | 2012-11-07 |
| AU2011216950A1 (en) | 2012-08-23 |
| TW201141856A (en) | 2011-12-01 |
| CA2788656A1 (en) | 2011-08-25 |
| UY33225A (es) | 2011-09-30 |
| MX2012008721A (es) | 2012-08-17 |
| JP2013519722A (ja) | 2013-05-30 |
| US20120041026A1 (en) | 2012-02-16 |
| WO2011101774A1 (en) | 2011-08-25 |
| SG183111A1 (en) | 2012-09-27 |
| ZA201206469B (en) | 2013-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN06631A (de) | ||
| MX2011010223A (es) | Despliegue de juego de casino que se puede vestir y sistema de rastreo. | |
| HK1139930A1 (en) | Cyclopamine lactam analogs and methods of use thereof | |
| TW200720693A (en) | A comfortable ophthalmic device and methods of its production | |
| SG176656A1 (en) | Microorganisms for the production of 1,4-butanediol and related methods | |
| UA98312C2 (en) | Progesterone receptor antagonists | |
| MX2011012599A (es) | Compuestos polimericos de agentes inmunomoduladores. | |
| CO6551692A2 (es) | Nebulizador | |
| GB2481565A (en) | Screen capture | |
| EP3822352A3 (de) | Verfahren und zusammensetzungen zur modulation der apolipoprotein(a)-expression | |
| MX362362B (es) | Pilar dental para el soporte de protesis dentales y metodo de fabricacion del mismo. | |
| NZ603625A (en) | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate | |
| AU2011305525A8 (en) | Modulators of the GPR119 receptor and the treatment of disorders related thereto | |
| MX2012000391A (es) | Composiciones farmaceuticas y formas solidas. | |
| MX2010010345A (es) | Composiciones oftalmicas topicas mejoradas. | |
| WO2011069095A3 (en) | Stuttering reduction method and device | |
| MY156946A (en) | Composition for decreasing hardness of water | |
| AU335053S (en) | Integrated winchhead | |
| EP2580229A4 (de) | D5-desaturase-defektives mutantengen und verwendung davon | |
| IN2014CN00817A (de) | ||
| TWM385327U (en) | Automatic body temperature measuring device and equipment | |
| UA49143U (ru) | Применение игрового автомата как развлекательного аппарата | |
| IN2014CN00834A (de) | ||
| WO2009120381A3 (en) | Faucet system and advertising method | |
| IN2014DN02984A (de) |